Eloxx Pharmaceuticals Stock (OTC: ELOX) stock price, news, charts, stock research, profile.
|Vol / Avg.31.764K / 27.811K||Mkt Cap3.272M|
|Day Range- - -||52 Wk Range0.945 - 10.900|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2022-05-23||Piper Sandler||Edward Tenthoff||Maintains||Overweight||Lowers||4.00||1.50|
|2022-05-09||HC Wainwright & Co.||Andrew Fein||Maintains||Neutral||Lowers||1.00||0.50|
You can purchase shares of Eloxx Pharmaceuticals (OTCPK: ELOX) through any online brokerage.
There are no as such competitors for Eloxx Pharmaceuticals.
The latest price target for Eloxx Pharmaceuticals (OTCPK: ELOX) was reported by Oppenheimer on Tuesday, July 11, 2023. The analyst firm set a price target for 55.00 expecting ELOX to rise to within 12 months (a possible 5040.19% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Eloxx Pharmaceuticals (OTCPK: ELOX) is $1.07 last updated November 29, 2023 at 8:56 PM UTC.
There is no dividend information for Eloxx Pharmaceuticals.
Eloxx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Eloxx Pharmaceuticals.
Eloxx Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.